| |
Single treatment |
Combined treatment |
p-value |
| Evaluation |
n |
% |
n |
% |
| 4 weeks |
|
|
|
|
|
| Worsened |
0 |
0 |
2 |
10.5 |
0.5851 |
| No change |
6 |
54.5 |
6 |
31.6 |
| Improved |
5 |
45.5 |
10 |
52.6 |
| Markedly improved |
0 |
0 |
1 |
5.3 |
| Not determined |
0 |
0 |
0 |
0 |
| Total |
11 |
100 |
19 |
100 |
- |
| 8 weeks |
|
|
|
|
|
| Worsened |
0 |
0 |
1 |
5.9 |
0.6832 |
| No change |
1 |
9.1 |
4 |
23.5 |
| Improved |
9 |
81.8 |
10 |
58.8 |
| Markedly improved |
1 |
9.1 |
2 |
11.8 |
| Not determined |
0 |
0 |
0 |
0 |
| Total |
11 |
100 |
17 |
100 |
- |
| 12 weeks |
|
|
|
|
| Worsened |
0 |
0 |
0 |
0 |
0.7005 |
| No change |
3 |
27.3 |
4 |
23.5 |
| Improved |
4 |
36.4 |
4 |
23.5 |
| Markedly improved |
4 |
36.4 |
9 |
52.9 |
| Not determined |
0 |
0 |
0 |
0 |
| Total |
11 |
100 |
17 |
100 |
- |
|
